# FDA Inspection 1305822 - Reflow Medical - March 05, 2026

Source: https://www.keypedia.com/records/fda_inspections/reflow-medical/c6cd64b6-6804-45ed-84fb-d1145e945506
Source feed: FDA_Inspections

> FDA Inspection 1305822 for Reflow Medical on March 05, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305822
- Company Name: Reflow Medical
- Inspection Date: 2026-03-05
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Devices
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1305822 - 2026-03-05](https://www.keypedia.com/records/fda_inspections/reflow-medical/cf0d0a9e-1ef2-4b91-8afe-2b0b69bab544)
- [FDA Inspection 1305822 - 2026-03-05](https://www.keypedia.com/records/fda_inspections/reflow-medical/8159d5ee-32c3-4b82-ae16-1a8ea6b491ab)

Company: https://www.keypedia.com/companies/reflow-medical/630726f8-9449-4b2b-a8c2-c1b722acac50

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b